Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

A supercomputer is about to launch to the moon aboard a rover named FLIP

HAWTHORNE, Calif. — A moon buggy carrying a history-making supercomputer is ready to launch to the lunar surface. And it’s taking some inspiration from Mars.

Later this year, Astrolab will launch its uncrewed moon rover FLIP to the lunar south pole as part of the Griffin Mission 1, or Griffin-1. The California company is one of two that NASA has selected to develop a drivable rover for the agency’s Artemis program. On board FLIP will be Hewlett Packard Enterprise’s (HPE) Spaceborne Computer-4, an advanced computer module built to be used in space.

An Artificial Intelligence Model for Translating Natural Language into Functional De Novo Proteins

Riley et al. created a protein design model (called MP4) with which users can explain desired protein properties via written descriptions and then generate predicted de novo proteins with those properties. As one of the demonstrations of MP4, they showed that it can create ATPase enzymes which display enzymatic activity in vitro. While not the first example of a text-to-protein model, MP4 does score better on many metrics than existing similar models like Pinal.


Abstract. Traditional protein design is fundamentally constrained by known sequences and folds. To break free from these limitations, we introduce a new alternative: designing proteins directly from plain-language specifications. To achieve this, we trained MP4, a transformer-based model that maps natural language prompts to protein sequences, on a dataset of 3.2 billion points and 138k tokens. In a benchmark of 96 prompts representing a wide array of functions and contexts, MP4 excelled by simultaneously improving on three key metrics: sequence realism, predicted fold quality, and alignment to the requested function. This high performance is particularly significant as it was achieved using only text as input which is a major departure from other models. Experimental validation confirmed our computational predictions: two de novo designs were experimentally shown to be both expressible and thermostable, with high-resolution crystallography (1.30 Å and 1.77 Å) ultimately revealing one to possess a paradigm-shifting novel fold. Functionally, the designs were also active, demonstrating both ATP binding and hydrolysis in vitro. This work demonstrates the realization of natural-language intent as functional proteins that express, crystallize, and catalyze. Although the underlying approach is still in early development with incomplete coverage and controllability, MP4 delivers a profound impact: it lowers the barrier to protein design and vastly expands the space for creative exploration in molecular programming.

Physicists Trapped a Particle of Antimatter And Kept It Caged For Months

The Universe, according to theory at least, should not exist.

Every particle in the Universe has a corresponding antimatter counterpart. Should ever a pair of such particles meet, they would immediately cancel each other out – annihilated in a tiny puff of energy.

Theoretically, the birth of the Universe should have produced equal quantities of particles and antiparticles.

AI identifies tumor aging patterns to predict immunotherapy response across multiple cancer types

Even when given the same drug, some patients respond well while others show little or no response. This is particularly true of immunotherapy. A research team at POSTECH (Pohang University of Science and Technology) has developed an artificial intelligence (AI) technology that can predict, in advance, which patients are likely to benefit from treatment.

A research team led by professor Sanguk Kim of the Department of Life Sciences and the Graduate School of Convergence Science and Technology at POSTECH, together with Minsoo Kim, an integrated MS-Ph. D. student at the Graduate School of Artificial Intelligence, has developed a machine-learning method that analyzes genetic information from cancer patients to predict their response to immunotherapy. The study was recently published in npj Digital Medicine.